Company · CIK 0001285819 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
OMEROS CORP · OMER
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 9:00 pm EDT | David J. BorgesVP, Finance & CAO | 20,000 | $20.95 | $419,000 | 0 | −100% | 10b5-1 |
| Sep 22, 2026 MForm 4 → | Sep 24, 9:00 pm EDT | David J. BorgesVP, Finance & CAO | 20,000 | $9.51 | $190,150 | 10,000 | — | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Sep 1, 4:41 pm EDT | Peter B CancelmoVP, General Counsel | 50,000 | $18.59 | $929,668 | 200 | −99.6% | |
| Aug 28, 2026 MForm 4 → | Sep 1, 4:41 pm EDT | Peter B CancelmoVP, General Counsel | 50,000 | $2.94 | $147,000 | 25,200 | — | |
| Aug 26, 2026 SForm 4 → | Aug 28, 4:31 pm EDT | Arnold C HanishDirector | 15,000 | $18.81 | $282,094 | 0 | −100% | |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:31 pm EDT | Arnold C HanishDirector | 15,000 | $15.24 | $228,525 | 10,000 | — | |
| Aug 21, 2026 SForm 4 → | Aug 25, 5:40 pm EDT | David J. BorgesVP, Finance & CAO | 10,906 | $18.96 | $206,805 | 0 | −100% | 10b5-1 |
| Aug 21, 2026 MForm 4 → | Aug 25, 5:40 pm EDT | David J. BorgesVP, Finance & CAO | 10,906 | $3.48 | $37,911 | 906 | — | 10b5-1 |
| Aug 20, 2026 SForm 4 → | Aug 21, 5:34 pm EDT | Thomas J. CableDirector | 15,000 | $18.45 | $276,773 | 35,067 | −30.0% | |
| Aug 20, 2026 MForm 4 → | Aug 21, 5:34 pm EDT | Thomas J. CableDirector | 15,000 | $2.97 | $44,475 | 50,067 | — | |
| Aug 13, 2026 SForm 4 → | Aug 17, 7:42 pm EDT | David J. BorgesVP, Finance & CAO | 5,000 | $16.95 | $84,750 | 0 | −100% | 10b5-1 |
| Aug 13, 2026 MForm 4 → | Aug 17, 7:42 pm EDT | David J. BorgesVP, Finance & CAO | 5,000 | $3.93 | $19,650 | 5,000 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 MForm 4 → | Sep 24, 9:00 pm EDT | David J. BorgesVP, Finance & CAO | 20,000 | — | — | 5,000 | — | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Sep 1, 4:41 pm EDT | Peter B CancelmoVP, General Counsel | 50,000 | — | — | 50,000 | — | |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:31 pm EDT | Arnold C HanishDirector | 15,000 | — | — | 0 | — | |
| Aug 21, 2026 MForm 4 → | Aug 25, 5:40 pm EDT | David J. BorgesVP, Finance & CAO | 10,906 | — | — | 20,000 | — | 10b5-1 |
| Aug 20, 2026 MForm 4 → | Aug 21, 5:34 pm EDT | Thomas J. CableDirector | 15,000 | — | — | 0 | — | |
| Aug 13, 2026 MForm 4 → | Aug 17, 7:42 pm EDT | David J. BorgesVP, Finance & CAO | 5,000 | — | — | 15,000 | — | 10b5-1 |
| Aug 12, 2026 AForm 4 → | Aug 18, 9:51 pm EDT | Joseph L SchockenDirector | 30,000 | — | — | 30,000 | — | late |
| Jul 22, 2026 AForm 4 → | Jul 24, 9:17 pm EDT | Gregory A Demopulos M.D.Chairman, CEO & President, Director | 1,000,000 | — | — | 1,000,000 | — | |
| Jul 22, 2026 AForm 4 → | Jul 24, 9:13 pm EDT | Peter B CancelmoVP, General Counsel | 105,000 | — | — | 105,000 | — | |
| Jul 22, 2026 AForm 4 → | Jul 24, 9:11 pm EDT | David J. BorgesVP, Finance & CAO | 105,000 | — | — | 105,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 7:35 am EDT | Rajiv ShahDirector | 15,000 | — | — | 15,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 7:34 am EDT | Diana T. PerkinsonDirector | 15,000 | — | — | 15,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 7:34 am EDT | Leroy E. Hood M.D. Ph.D.Director | 15,000 | — | — | 15,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 7:33 am EDT | Arnold C HanishDirector | 15,000 | — | — | 15,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 7:33 am EDT | Peter A Demopulos M.D.Director | 15,000 | — | — | 15,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 7:32 am EDT | Thomas J. CableDirector | 15,000 | — | — | 15,000 | — | |
| Jun 18, 2026 AForm 4 → | Jun 22, 7:31 am EDT | Thomas F. BumolDirector | 15,000 | — | — | 15,000 | — |